Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.
Journal: JAMA otolaryngology-- head & neck surgery
Published: August 20, 2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 16, 2026
Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 06, 2026
Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications.
Journal: Head & neck
Published: December 08, 2025
The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED group.
Journal: Expert review of endocrinology & metabolism
Published: November 27, 2025
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy.
Journal: JCO precision oncology
Published: July 09, 2025
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: July 03, 2025
Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer.
Journal: Head & neck
Published: June 26, 2025
Circulating Tumor DNA as a Biomarker for Disease Surveillance in Anaplastic Thyroid Cancer.
Journal: JCO precision oncology
Published: June 26, 2025
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.
Journal: Arthritis care & research
Published: May 27, 2025
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 27, 2025
Last Updated: 09/26/2026